AU Stock MarketDetailed Quotes
CU6 Clarity Pharmaceuticals Ltd
- 5.080
- +0.410+8.78%
20min DelayMarket Closed May 31 16:00 AET
1.58BMarket Cap-53473P/E (Static)
5.100High4.640Low2.95MVolume4.730Open4.670Pre Close14.64MTurnover5.10052wk High1.39%Turnover Ratio311.01MShares0.67552wk Low-0.118EPS TTM1.08BFloat Cap5.100Historical HighLossP/E (Static)212.35MShs Float0.360Historical Low-0.095EPS LYR9.85%Amplitude--Dividend TTM29.71P/B1Lot Size--Div YieldTTM
About Clarity Pharmaceuticals Ltd Company
Clarity Pharmaceuticals Ltd is a clinical-stage radiopharmaceutical company developing next-generation theranostic (therapy and imaging) products, based on its platform SAR Technology. The SAR technology is ideally suited for use with copper isotopes, enabling superior imaging and therapeutic characteristics of radiopharmaceutical products and addressing the current manufacturing and logistical limitations in the growth of the radiopharmaceutical sector in oncology.
Company Profile
SymbolCU6
Company NameClarity Pharmaceuticals Ltd
Founded2010
MarketASX
Fiscal Year Ends06-30
Address4 Cornwallis Street National Innovation Centre
CitySydney
CountryAustralia
Zip Code2015
Phone+61 292094037
Company Executives
- Name
- Position
- Salary
- Colin David Biggin
- Chief Executive Officer,Managing Director
- --
- Alan John Taylor
- Executive Chairman,Executive Director
- --
- Thomas Ramdahl
- Non-Executive Director
- --
- Rosanne Elizabeth Robinson
- Non-Executive Director
- --
- Robert Bain Thomas
- Non-Executive Director
- --
- Christopher Graham Roberts
- Non-Executive Director
- --
- Cheryl Ann Maley
- Non-Executive Director
- --
Analysis
Price Target
No Data
Heat List
AU
Overall
Symbol
Latest Price
%Chg